- Drug Pipelines
- September 2018
- 128 Pages
Global
From €3368EUR$3,500USD£2,849GBP
Histone Deacetylase 2 (HDAC2) is an enzyme that plays a role in gene expression and chromatin remodeling. It is a member of the histone deacetylase family of enzymes, which are involved in the regulation of gene expression by removing acetyl groups from histones. HDAC2 is involved in a variety of cellular processes, including cell cycle progression, apoptosis, and differentiation. It has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
The HDAC2 market is composed of a variety of companies that produce and sell HDAC2-related products, such as enzymes, antibodies, and inhibitors. These products are used in research and drug discovery, as well as in the development of therapeutics. Companies in the HDAC2 market include Abcam, Merck KGaA, Sigma-Aldrich, Cell Signaling Technology, and Bio-Techne. Show Less Read more